首页> 外文期刊>Biological & pharmaceutical bulletin >Investigation on the Interactions between Various Drugs and Aojiru (Green Juice) Using a Simple Centrifugation Method
【24h】

Investigation on the Interactions between Various Drugs and Aojiru (Green Juice) Using a Simple Centrifugation Method

机译:用简单的离心方法调查各种药物与Aojiru(绿汁)的相互作用

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this study was to evaluate the interactions between various drugs and aojiru (green juice), a popular health food in Japan, using a simple centrifugation method. The mixture of drug solution and aojiru suspension was gently shaken and centrifuged. The drug concentration in the supernatant fluid was then determined by HPLC. The concentration of rhodamine 123 (Rho-123), a model compound, in the supernatant fluid significantly decreased after mixing with aojiru, indicating extensive binding of Rho-123 to the insoluble components of aojiru. When administered into rat small intestinal loops together with aojiru, the plasma Rho-123 concentrations became much smaller than those when administered alone. This result strongly suggested that a strong interaction observed in vitro was well reflected in modulated absorption. Among seven drugs tested, chlorpromazine and imipramine exerted binding properties to aojiru similar to or greater than Rho-123. As a small part of both Rho-123 and imipramine was released when the aojiru precipitate was resuspended, their binding to aojiru was considered to be tight. The binding of diltiazem, fexofenadine, glibenclamide, metformin, and norfloxacin to aojiru was much weaker or almost negligible compared with that of chlorpromazine and imipramine. The present results suggest that aojiru can decrease the intestinal absorption of some clinically relevant drugs through tight binding in the small intestine and that the present centrifugation method is useful for predicting in vivo interactions between drugs and aojiru.
机译:本研究的目的是评估各种药物和Aojiru(绿色汁)之间的相互作用,使用简单的离心方法。药物溶液和Aojiru悬浮液的混合物轻轻地摇动并离心。然后通过HPLC测定上清液中的药物浓度。在与Aojiru混合后,上清液中的罗丹明123(RHO-123),模型化合物,模型化合物的浓度显着降低,表明RHO-123与Aojiru的不溶性组分的广泛结合。当与Aojiru一起施用大鼠小肠环时,等离子体RHO-123浓度比单独给药时比那些小得多。该结果强烈建议在玻璃体外观察到的强烈相互作用在调节吸收中良好地反映。在测试的七种药物中,氯丙嗪和含丙氨酸与类似于或大于rhO-123的Aojiru施加结合性质。当重新悬浮Aojiru沉淀时释放出rho-123和脂蛋白的一小部分,认为它们与Aojiru的结合被认为是紧密的。与氯丙嗪和含氨胺相比,Diltiazem,FexofenaDine,Glibenclamide,二甲双胍和NORFLOXACIN与Aojiru的结合与Aojiru相比重大或几乎可以忽略不计。目前的结果表明,Aojiru通过小肠中的紧密结合可以降低一些临床相关药物的肠道吸收,并且本发明的离心方法可用于预测药物和Aojiru之间的体内相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号